Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The EVLV SEC filings page on Stock Titan aggregates regulatory documents for Evolv Technologies Holdings, Inc., whose Class A common stock and warrants trade on The Nasdaq Stock Market under the symbols EVLV and EVLVW. These filings provide structured insight into how the company reports its financial performance, capital structure, governance decisions, and key agreements related to its AI-powered security screening business.
Among the most closely watched documents for Evolv are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which detail revenue composition between recurring subscription and non-recurring product and services, discuss metrics such as Annual Recurring Revenue, and describe risks and operational considerations connected to its security technology offerings. Current reports on Form 8-K disclose specific material events, including the announcement of quarterly financial results, entry into credit agreements, changes in executive roles, and outcomes of shareholder votes at the annual meeting.
Filings also describe Evolv’s capital and financing arrangements, such as senior secured credit facilities documented in a Credit, Security and Guaranty Agreement, and registration statements or post-effective amendments that address the registration of securities and warrant exercises. Proxy materials and related disclosures explain matters submitted to stockholders, including director elections, advisory votes on executive compensation, and auditor ratification.
On Stock Titan, EVLV filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered summaries help explain lengthy filings by highlighting key points, such as changes in liquidity, covenant requirements, revenue mix, or governance decisions, without replacing the underlying source documents. Users can also review Section 16 and Form 4 filings to monitor insider transactions and equity awards, adding another dimension to their analysis of Evolv’s governance and incentive structures.
Together, these filings form a detailed record of how Evolv communicates with regulators and investors about its financial condition, risk factors, and significant corporate events related to its AI-based security technology business.
Evolv Technologies Holdings, Inc. reported that director Henrik Kuhl acquired 9,291 restricted stock units (RSUs) as a grant. Each RSU represents a contingent right to receive one share of Class A common stock and has no expiration date.
The RSUs will vest in full at the earlier of June 20, 2026 or the day immediately before the company’s next annual meeting. Following this grant, Kuhl holds a total of 9,291 RSUs directly.
Evolv Technologies Holdings, Inc. director Henrik Kuhl filed an initial insider ownership report on Form 3. This filing establishes his status as a director and formally records his position as an insider, but it does not report any share purchases, sales, or other transactions.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen exercised a stock option for 80,745 shares on February 17, 2026, converting options at an exercise price of $0.24 per share into Class A common stock. The same day, he sold 80,745 Class A shares in an open-market transaction at a weighted average price of $5.47 per share, with individual trades ranging from $5.39 to $5.65, under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025. Following these transactions, he directly owned 2,083,961 Class A shares and indirectly held 151,135 shares through Family Horizon Trust.
Evolv Technologies Holdings, Inc. announced a Board change, with long-time director and early venture investor Bilal Zuberi resigning to pursue other endeavors, with no disagreements cited with leadership or the Board.
The company appointed Henrik Kühl, age 46, to its Board of Directors effective February 12, 2026, as a Class III director through the 2027 annual meeting. He will also serve on the Audit Committee. The Board determined that Kühl is independent under Nasdaq and SEC rules and qualifies as an “audit committee financial expert.”
Kühl brings more than 25 years of experience in corporate strategy and development, including his current role as Senior Vice President, Strategy & Corporate Development at Axon. He will receive compensation as a non-employee director under Evolv’s Director Compensation Policy.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported option exercises and share sales in Class A Common Stock. On January 16, 2026, he exercised a stock option for 80,745 shares at an exercise price of
After these transactions, Ellenbogen directly beneficially owned 2,083,961 shares of Class A Common Stock and held 1,300,739 stock options. He also indirectly held 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings, Inc. reported that director Mark J. Sullivan received a grant of 3,731 Restricted Stock Units (RSUs) on January 2, 2026. Each RSU represents a contingent right to receive one share of the company’s Class A common stock at no purchase price, and the RSUs have no expiration date.
The filing states that these 3,731 RSUs will vest in full on December 31, 2026, after which they can settle into an equal number of Class A common shares, assuming vesting conditions are met. Following this award, Sullivan beneficially owns 3,731 RSUs directly.
Evolv Technologies Holdings, Inc. (EVLV) reported a new equity grant to one of its directors. Director Michael Ellenbogen was awarded 3,731 Restricted Stock Units (RSUs) on January 2, 2026, at a price of $0 per unit, and now holds 3,731 derivative securities directly following this transaction.
Each RSU represents a contingent right to receive one share of Evolv’s Class A common stock and has no expiration date. According to the disclosure, all 3,731 RSUs will vest in full on December 31, 2026, meaning Ellenbogen will receive an equal number of Class A shares if the vesting conditions are satisfied.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported insider transactions in Class A Common Stock. On December 15, 2025 he exercised stock options for 80,745 shares at an exercise price of $0.24 per share and on the same day sold 80,745 shares at a weighted average price of $6.91 per share under a Rule 10b5-1 trading plan entered into on June 12, 2025. The sales occurred in multiple trades at prices ranging from $6.75 to $7.20.
After these transactions he held 2,083,961 shares directly, 151,135 shares indirectly through the Family Horizon Trust, and 1,381,484 stock options.
Evolv Technologies Holdings, Inc. (EVLV) executive Robert Marshall, the company’s Chief Revenue Officer, reported an open-market purchase of Class A common stock. On 11/25/2025, he acquired 7,000 shares at a price of $6.06 per share, reported with transaction code "P" for a purchase. Following this transaction, he beneficially owns 7,000 Class A shares, held directly.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by its President & CEO and Director, John Kedzierski. On 11/21/2025, the reporting person bought 8,000 shares of Class A common stock in an open market transaction at a weighted average price of $5.91 per share. The filing notes the shares were acquired in multiple trades at prices ranging from $5.89 to $5.91, and the reporting person has offered to provide full trade details upon request. After this transaction, the insider directly holds 8,000 shares.